NUS Stock Recent News
NUS LATEST HEADLINES
Nu Skin (NUS) is on track with its Nu Vision 2025 strategy. However, the company is operating amid macroeconomic hurdles.
PROVO, Utah , Oct. 3, 2023 /PRNewswire/ -- Nu Skin Enterprises, Inc. (NYSE: NUS) today announced it will release third quarter 2023 results after the market closes on Wednesday, Nov. 1. The Nu Skin management team will host a conference call with the investment community later that same day at 5 p.m.
Nu Skin (NUS) is witnessing continued macroeconomic hurdles and an inflationary environment. The company is also battling unfavorable currency movements.
Nu Skin Enterprises had been impacted by COVID-19 initially and tough macro-environment recently, leading to a decline in sales and lowered guidance for 2023. The company reported resilient Q2 earnings with sustained gross margins and in line EPS supported by strong growth in China. Despite the challenges, the valuation appears attractive at just 8.7x Fwd PE and a forward dividend yield of 6.7%.
Nu Skin's (NUS) margins have been contracting year over year for a while now. The company is also battling unfavorable currency headwinds.
Nu Skin (NUS) is battling continued macroeconomic hurdles and related price increases, affecting specific key markets, leading to a slowdown in consumer spending and customer acquisition.
Nu Skin (NUS) reports sequential improvements in Q2 results, driven by the Mainland China and Rhyz segments. However, macro-economic factors pose challenges in the key markets.
NU Skin Enterprises, Inc. (NYSE:NUS ) Q2 2023 Earnings Conference Call August 1, 2023 5:00 PM ET Company Participants Scott Pond - VP, IR Ryan Napierski - President, CEO & Director Connie Tang - EVP & Chief Global Growth & Customer Experience Officer James Thomas - Interim CFO Conference Call Participants Chasen Bender - Citi Blake Anderson - Jefferies Christopher Armes - Stifel Linda Bolton-Weiser - D.A. Davidson Operator Good day, ladies and gentlemen.
Nu Skin Enterprises (NUS) came out with quarterly earnings of $0.54 per share, beating the Zacks Consensus Estimate of $0.53 per share. This compares to earnings of $0.77 per share a year ago.
Nu Skin's (NUS) second-quarter 2023 performance will likely reflect macroeconomic challenges like rising global inflation. Also, unfavorable currency rates are a concern.